Article successfully added.

CyFlow™ EGFR Purified

CyFlow™ EGFR Purified
Antibody: Yes
Antigen: EGFR (Phospho-Tyr1173)
Application: Flow cytometry, Immunoprecipitation, Western blot
Clonality: monoclonal
Clone: EM-13
Field of Interest: Phosphorylation
Format/Fluorochrome: Purified
Isotype: IgG1
Regulatory Status: RUO
Source Species: Mouse
Target Species: Human
Product number: BV927376

For Research Use Only

$120.00 USD*

Price excludes any applicable taxes plus shipping costs

Description Documentation TDS & SDS
Description
Concentration Unit mg/mL Concentration 1 Quantity 0.1 mg Volume 0.1 mL... more
Close menu
CyFlow™ EGFR Purified
Concentration Unitmg/mL
Concentration1
Quantity0.1 mg
Volume0.1 mL
ImmunogenSynthetic phospho-peptide covering sequence around tyrosine 1173 of human EGFR
Background InformationOncoprotein EGFR (epidermal growth factor receptor), also known as HER1 or ErbB1, is a member of ErbB family of cell surface receptor tyrosine kinases. This 170 kDa transmembrane glycoprotein is often associated with cancerogenesis, although its activation state is controlled at various levels including trafficking and degradation steps. Binding of receptor-specific ligands to the EGFR ectodomain results in formation of homodimeric or heterodimeric kinase-active complexes into which HER2/ErbB2 is recruited as a preferred partner. Subsequent signaling cascades such as RAS/MAPK and PI3K/AKT pathways lead to cell proliferation and survival responses.
Storage BufferThe reagent is provided in phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.
Specific References

| Batzer AG, Blaikie P, Nelson K, Schlessinger J, Margolis B: The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor. Mol Cell Biol. 1995 Aug; 15(8):4403‑9. < PMID: 7542744 > | Moulder SL, Yakes FM, Muthuswamy SK, Bianco R, Simpson JF, Arteaga CL: Epidermal growth factor receptor (HER1 tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)‑overexpressing breast cancer cells in vitro and in vivo. Cancer Res. 2001 Dec 15; 61(24):8887‑95. < PMID: 11751413 > | Daniele T, Di Tullio G, Santoro M, Turacchio G, De Matteis MA: ARAP1 regulates EGF receptor trafficking and signalling. Traffic. 2008 Dec; 9(12):2221‑35. < PMID: 18764928 > | Rappl A, Piontek G, Schlegel J: EGFR‑dependent migration of glial cells is mediated by reorganisation of N‑cadherin. J Cell Sci. 2008 Dec 15; 121(24):4089‑97. < PMID: 19033391 > | Gandhi J, Zhang J, Xie Y, Soh J, Shigematsu H, Zhang W, Yamamoto H, Peyton M, Girard L, Lockwood WW, Lam WL, Varella-Garcia M, Minna JD, Gazdar AF: Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. PLoS ONE. 2009; 4(2):e4576. < PMID: 19238210 > | Yan F, Cao H, Chaturvedi R, Krishna U, Hobbs SS, Dempsey PJ, Peek RM Jr, Cover TL, Washington MK, Wilson KT, Polk DB: Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori‑induced apoptosis. Gastroenterology. 2009 Apr; 136(4):1297‑1307, e1‑3. < PMID: 19250983 >

TDS & SDS
Close menu

Technical Data Sheet

Safety Data Sheet